loader
Please Wait
Applying Filters...

Annual Sales of Alectinib Hydrochloride reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Alecensa

PharmaCompass

01

Brand Name : Alecensa

Alectinib

arrow
Luxepack
Not Confirmed

02

Brand Name : Alecensa

Alectinib

arrow
Discovery on Target
Not Confirmed

Brand Name : Alecensa

arrow
Discovery on Target
Not Confirmed

Alectinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,292

2019 Revenue in Millions : 976

Growth (%) : 32

blank

03

Brand Name : Alecensa

Alectinib

arrow
Discovery on Target
Not Confirmed

Brand Name : Alecensa

arrow
Discovery on Target
Not Confirmed

Alectinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 1,459

2020 Revenue in Millions : 1,230

Growth (%) : 17

blank

04

Brand Name : Alecensa

Alectinib

arrow
Discovery on Target
Not Confirmed

Brand Name : Alecensa

arrow
Discovery on Target
Not Confirmed

Alectinib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 1,654

2021 Revenue in Millions : 1,459

Growth (%) : 13

blank

05

Brand Name : Alecensa

Alectinib

arrow
Discovery on Target
Not Confirmed

Brand Name : Alecensa

arrow
Discovery on Target
Not Confirmed

Alectinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 1,743

2022 Revenue in Millions : 1,654

Growth (%) : -1

blank

06

Brand Name : Alecensa

Alectinib Hydrochloride

arrow
Discovery on Target
Not Confirmed

07

Brand Name : Alecensa

Alectinib Hydrochloride

arrow
Discovery on Target
Not Confirmed

Brand Name : Alecensa

arrow
Discovery on Target
Not Confirmed

Alectinib Hydrochloride

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 643

2017 Revenue in Millions : 366

Growth (%) : 76%

blank